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A B S T R A C T
PCOS, the leading cause of anovulatory infertility that affects up to one fifth of the
female population, is a complex chronic disease of genetic as well as environmental de-
termination, but still unclear etiology. Besides of infertility, PCOS leads to menstrual
dysfunctions, hirsutism and obesity – symptoms that are known to cause profound psy-
chosocial distress. The present paper review the problematic of etiology and symptom
expression of PCOS, which is not only a disease needing medical treatment but also a
psychosocial problem for the affected women. PCOS may not only coinduced by psy-
chosocial factors, the main symptoms of PCOS such as infertility, menstrual dysfunc-
tions, hirsutism and obesity cause by themselves increased psychosocial stress.
Introduction
Although the world population rea-
ched six billion people shortly ago, infer-
tility is an increasing problem. Approxi-
mately 20% of couples in Western so-
cieties experience infertility1, being one
third due to the combined infertility of
both the partners, another third to the
women alone, and one fifth to men alone2.
Besides the well known demographic and
economic effects of decreasing population
size, infertility represents first of all a
personal problem for the affected individ-
uals. Especially for the infertile women,
childlessness is an enormous psychologi-
cal burden often associated with divorce,
low social status and lowered self-percep-
tion because motherhood is perceived as
an important part of female identity. In-
fertility occurs in association with vari-
ous disorders, the most common cause of
anovulatory infertility however, is the Po-
lycystic Ovary Syndrome3, affecting ap-
proximately 5% of the female population
of reproductive age4, independent of eth-
nicity. In clinical practice, women with
this diagnosis are seen for four main
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symptoms: infertility, menstrual irregu-
larity, obesity, and hirsutism5,6. The symp-
toms on their own as well as in associa-
tion are known to cause profound
psychosocial impact. Although the etiol-
ogy is far from being understood, it seems
clear that genetic, behavioural and psy-
chosocial factors7–15 play import roles in
the pathogenesis of PCOS in which clini-
cal and endocrinologic features are highly
variable. Thus, success of treatment is
likewise variable, ranging from recurren-
ce of symptoms shortly after termination
of treatment to spontaneous cure9,16. Due
to the interaction of genetic and environ-
mental/ behavioural factors contributing
to its pathogenesis, PCOS is an interest-
ing model to study the old and still unre-
solved question of nature-nurture dichot-
omy in the realm of health and disease.
Diseases usually result from webs of in-
teracting causes of enormous comple-
xity17, however, in most instances, pro-
grams of research tend to emphasise a
single cause. Diseases such as PCOS,
which comprise so many different symp-
toms are clearly a medical condition but
they are also psychosocial problems. The
reasons to use PCOS as a model to study
the psychosocial factors involved in symp-
tom perception are as follows:
1. Fertility is an important biological fun-
ction and is universal to all human beings
throughout time and space, and, apart
from being a biological process, reproduc-
tion among Homo sapiens has always had
strong connections to culture and to psy-
chosocial factors. Cultural aspects like
socio-economic and socio-educational lev-
els, nutrition, religion, tradition, weaning
habits, and different psychosocial factors
influence reproductive success and fertil-
ity outcome. Pathological as well as volun-
tary infertility, minimising reproductive
success, are in contrast to the biological
imperative and are expected to produce
great psychosocial distress.
2. Apart from infertility, some of the other
symptoms associated with PCOS (like
hirsutism, obesity, and android fat pat-
terning) may interfere with female self
-perception and are in contradiction to
culture dependent beauty ideals18.
The present paper is a review of the
literature on psychosocial features of pa-
tients affected with PCOS. The aims of
this review are twofold. First, there is the
aim to discuss psychosocial factors associ-
ated with PCOS as a whole or alterna-
tively of the four main symptoms.. Sec-
ondly, the psychosocial consequences of
bearing the full blown syndrome or alter-
natively one of the four symptoms are ad-
dressed.
Methods
The articles reviewed in the present
paper represent a search through MED-
LINE until July 2000, in addition to some
other punctual papers found in other da-
tabases or libraries. The inclusion crite-
ria adopted had to be very ample, since
relatively few papers on psychosocial fac-
tors and PCOS were published. And, as
stated above, papers on the bio/psycho-
social factors associated with one of the
four main symptoms alone without them
being diagnostic of PCOS were also in-
cluded.
Status of Research of the
Polycystic Ovary Syndrome
Definition and epidemiology
Despite early studies of this disease
the etiology and pathophysiology of the
PCOS are poorly understood up to now11.
The prevalence of the PCOS lies between
3 and 22% depending on the definition
used. Diagnostic criteria include a wide
spectrum of clinical phenotypes, ranging
from women with anovulatory regular
menstrual cycles to hirsute, obese, oligo-
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amenorrhoeic infertile women19. More re-
cently, this syndrome was characterised
by chronic anovulation and some eviden-
ce of androgen excess20, leading to a prev-
alence of about 5%21. This definition re-
flects the consensus of experts, however,
no single criterion is endorsed as defi-
nite20. Although the polycystic appear-
ance of the ovaries was used as diagnostic
criterion for PCOS in the past, this mor-
phological feature is no longer univer-
sally accepted because of its non-speci-
ficity22,23. Indeed, it can also be found as a
secondary consequence of other condi-
tions such as late onset adrenal 21-hy-
droxylase deficiency, adrenal or ovarian
androgen secreting tumors, syndromes of
extreme insulin resistance, as well as
Cushing’s syndrome and acromegaly24.
However, it can also be diagnosed among
healthy women. Altogether, as much as
22% of the female population have po-
lycystic ovaries8, but only 3–10% of them
can be classified as affected with the
PCOS13. It is important to note that wo-
men with PCO morphology and no other
symptoms have similar fertility in com-
parison to normal circulating controls24.
This raises the issue whether the poly-
cystic morphology is a normal biological
variation or the very mild end of the wide
spectrum of PCOS19,24,25.
Hormonal levels
PCOS is also referred to as an endo-
crine disorder characterised by hyperan-
drogenism, although no specific androgen
pattern is predictive of PCOS. For exam-
ple, as much as 30–50% of women with
PCOS have normal testosterone levels26.
Women with PCOS tend also to show
high LH/FSH ratios and an increase in
the circadian frequency of LH pulses in
comparison to healthy controls, however,
controversy exists whether these alter-
ations represent a primary or secondary
defect4. Additionally, the levels of pro-
lactin26, and growth factors25 may also be
altered.
Weight status, body composition,
fat distribution
From the first description of the syn-
drome, obesity was recognised in at least
half of the affected patients. More than
60 years later, the cause of obesity associ-
ated with PCOS remains unclear. The as-
sociation of obesity and PCOS is as fol-
lows: The percentage of obesity among
women affected with PCOS varies signifi-
cantly even between westernised coun-
tries, for example 38%–88%19 reflecting
genetic as well as environmental influ-
ences. However, higher body mass indices
(>24.99) at age 18 work as a predictor for
later anovulatory infertility15. PCOS af-
fected women show a typical android
kind of fat patterning (high waist/hip ra-
tio) in consequence of higher total andro-
gen levels27. This is a typical sign of infer-
tile or postreproductive phases in female
life28,29, being also observed during preg-
nancy and in obese young women whose
potential reproductive success is dimini-
shed30. Furthermore, obesity exacerbates
the underlying insulin-resistance in al-
ready established PCOS31, and is linked
to increased androgen production, hirsu-
tism and infertility19.
Genetic factors
The possibility that PCOS is geneti-
cally determined has been suggested for
over 40 years13. The pattern of inheri-
tance suggested was either autosomal do-
minant13,32 or X-linked dominant33, de-
pending on the criteria used to establish
the phenotype. More recent results sug-
gest genetic heterogeneity34, what is not
unexpected, since the prevalence of
PCOS and its associated symptoms vary
quite substantially among different po-
pulations35,36. Most authors acknowledge
strong environmental factors in addition
to the genetic predisposition37.
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PCOS as general risk factor
Apart from representing a complex
disorder in itself, PCOS predisposes for
different severe disease risks, such as
type II diabetes mellitus, dyslipedemia,
cardiovascular diseases, hypertension,
gestational diabetes and pregnancy-indu-
ced hypertension38. Higher risks for endo-
metrial and ovarian cancer38 are also of-
ten referred to by clinicians, despite its
controversy. Recent research suggests
that insulin-resistant PCOS occurs in
most hyperandrogenic obese women and
causes higher metabolic renal, and car-
diovascular risks as compared to nonhy-
perinsulinemic PCOS39.
Psychosocial Factors of PCOS and
of its Main Symptoms
There are only a few reports on the
psychosocial aspects of PCOS affected
women. Therefore the following will also
review the psychosocial factors associa-
ted with each of the main symptoms of
PCOS separately.
PCOS in general
The older literature on psychosocial
factors associated with PCOS is rare and
tends to be psychoanalytic only9,40 how-
ever a psychoanalytic approach does not
reflect the psychosocial problematic of
PCOS in a sufficient manner. From a
more psychophysiological point of view,
Lobo et al 23 studied norepinephrine me-
tabolites, platelet serotonin, adrenal an-
drogens and psychological stress in 23
women with PCOS, 10 with hypotha-
lamic-pituitary dysfunction and 25 con-
trols. In comparison to the controls,
PCOS patients scored significantly hi-
gher in the modified Life Events Inven-
tory and also showed a significantly grea-
ter mean number of Major Life Events. It
is suggested that psychosocial stress may
be implicated in the chronic anovulation
and hyperandrogenism of PCOS, al-
though the data do not permit any caus-
ative relation23. Also from a more neu-
rophysiological point of view the asso-
ciation between an aberrant puberty and
the development of PCOS was discussed
by Mechanick & Futterweit41. According
to their hypothesis, abnormal neural de-
velopment in the brain decreases the
hypophyseal set point for ovarian hor-
mone feedback, elevating LH. The inap-
propriate gonadotropin secretion is main-
tained by ovarian hyperandrogenemia,
which in association with arrested follicle
maturation results in anovulation. A re-
cent study supports the view that an ab-
normally premature adrenarche appears
to be an early sign for PCOS42. This, in
turn, can be interpreted as an aberrant
puberty as postulated earlier by Mecha-
nik & Futterweit41, although the underly-
ing mechanism possibly is different and
psychosocial aspects are not sufficiently
discussed.
Only two papers could be found on
psychiatric morbidity and PCOS43,44, but
psychosocial factors are not considered. A
recent paper suggests that women with
PCOS do not cope with experimentally
induced stress as well as do controls45,
suggesting that distress may affect them
more substantially. Another psychosocial
or psychosocial component of PCOS was
discussed in three papers which report a
higher rate of PCOS among female-to-
male transsexuals than in the general fe-
male population46–48.
Although studies focusing on psycho-
social aspects of PCOS are rare, the great
majority of experts acknowledge more or
less heavy psychosocial burden secondary
to this disorder. Since the scarcity on
bio/psychosocial data on PCOS affected
women does not permit a greater insight
into this issue, the following will review
the bio/psychosocial aspects related to the
main symptoms associated with this syn-
drome (menstrual irregularity, infertility,
hirsutism and obesity), but which not
necessarily include data on PCOS pa-
tients.
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Menstrual irregularity
Menstrual irregularity is a relatively
frequent complaint in the gynecological
clinic, which can be easily overcome in
many cases. Despite the fact that men-
strual symptomatology has received
much attention in recent years, little re-
search was carried out to disclose pat-
terns of its interplay with psychosocial
factors, although they are suggested to
play important roles in the recognition,
evaluation, and expression of these symp-
toms49. It is well established that strenu-
ous physical exercise can lead to changes
in characteristics of the menstrual cycle,
apparently through alterations of the
pulsatile release of GnRH50. In addition,
moderate stress, may increase the proba-
bility of long menstrual cycles in suscep-
tible individuals51. A recent study52 re-
vealed lowered fecundability among
highly distressed women with long men-
strual cycles (>35 days), whereas the fe-
cundability of women with normal cycle
lengths were not affected by distress.
Therefore it was concluded that psycho-
logical distress might be a risk factor for
reduced fertility among women with long
menstrual cycles52.
Infertility
As already stated, infertility worries
20% of western couples1. Prevalence of
current infertility varies from 3.6–14.3%
and lifetime prevalence of infertility from
12.5–32.6%1. When considering the mean
number of children per women, it is clear
that some populations differ significantly
from others. In most of the cases these
differences are due to socio-educational
factors: women in first-world countries
tend to have two children at most, whe-
reas those from underdeveloped coun-
tries have in general more than four53.
However, when considering infertility as
a pathological symptom, 2 to 32% of the
women in countries like Brazil and Ga-
bon53 have primary infertility due to re-
productive tract infections and sexually
transmitted diseases. Traditional groups,
like the!Kung of Southern Africa and ru-
ral populations of Ethiopia are also re-
ported to have high rates of infertility,
due not only to infectious diseases, but
also to ecological factors54,55.
Besides these, it has for long time
been acknowledged that fertility is highly
variable and subject to the most different
factors. Besides endogenous steroids,
ovarian function, nutrition, diet, age and
development56, also psychosocial factors
do influence fertility. Stress and other
psychosocial factors as cause for infertil-
ity are being discussed for decades. To ex-
plain why rates of reproductive failure
reach 50% of all conceptions among hu-
mans and similar proportions among the
majority of mammals, Wasser & Barash57
developed the Reproductive Filtering
Model. They argue that the high repro-
ductive costs have selected physiological
mechanisms that terminate reproductive
attempts when the probability of viable
offspring is low. This implies that the re-
productive system has evolved a high
physiological responsiveness to environ-
mental change58.
Indeed, several findings suggest that
psychosocial distress does contribute to
the etiology of reproductive failure59,60.
Infertile women show higher psycho-
social distress than controls61. However,
the hypothesis that psychosocial distress
triggers infertility received little support
until the late eighties because only a rela-
tively small percentage of infertile per-
sons show clinically significant distress
rates prior to infertility61 and even during
fertility treatment62,63. It seems out of
question that infertility causes psycho-
social distress, however, there are some
reports on the surprising normality of
psychosocial factors in couples undergo-
ing fertility treatment62–64. Furthermore
it has to be stated, that not only psy-
chosocial distress triggers infertility but
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infertility triggers psychosocial problems.
Several studies found no explicable dif-
ferences between infertile and fertile
women on stress-markers or psychologi-
cal tests for neuroticism, anxiety or social
adjustment65,66. According to this results,
contrary to what many affected women
believe and hope neither adoption nor
other stress reducing procedures or activ-
ities increase the chance to become preg-
nant67. The emotional problems of infer-
tile couples are associated with being
infertile but not causes infertility67–70.
For many affected couples infertility
means a life crisis and a toll in the quality
of their life71. The psychosocial problems
arisen following infertility are most often
reported to be distress, depression, anxi-
ety, sexual problems, marital and social
disadjustment, loss of control, and low-
ered self esteem62,72–76. The psychological
symptoms, as well as anxiety and depres-
sion scores in infertile women are similar
to those associated with serious medical
disorders like cancer, cardiac rehabilita-
tion and hypertension77,78. This, however,
does not mean that psychosocial distress,
depression, anxiety or even obsessive-
compulsive behaviour necessarily reach
clinical significance in couples treated for
infertility62,75. Nevertheless, the probabi-
lity of conception is lower in women with
a high trait anxiety79,80 and furthermore,
stress may influence the outcome of infer-
tility treatment80,81. It is speculated that
personality characteristic determine how
women experience and react to the stress
of infertility, and that these psychological
and endocrinological differences could in-
fluence their probability of conception.
Indeed, a recent paper suggests that
women with PCOS do not cope with ex-
perimentally induced stress as well as do
controls45.
In summary, authors continue to in-
vestigate if psychosocial distress triggers
infertility, since it seems well established
that infertility triggers psychosocial dis-
tress and that there is a bi-directional as-
sociation of both. However, despite the
growing support of the idea that only sub-
tle psychosocial distress and slight hor-
monal dysfunctions alter fertility in hu-
mans and in some animals – where, for
example, stress is associated to fetal re-
sorption in mammals82,83 – the underly-
ing mechanisms remain unknown52,80.
Hirsutism
Hirsutism, the excessive hair growth
in women following a male distribution
pattern, usually results from a combina-
tion of increased androgen production
and increased skin sensitivity to andro-
gens84. It is well known that the degree of
hirsutism varies quite markedly with
ethnicity. Later work focuses more on the
underlying physiology of hirsutism, its
association with infertility, and on differ-
ential frequency of hirsutism in fertile
women of different ethnicity85. Hirsu-
tism, although not considered a disease,
is a common problem that may be pre-
sented to clinicians or not depending on
cultural factors and ethnicity86. However,
hirsutism is often one of the complaints
made by patients affected with PCOS. Al-
though cosmetic and psychosexual conse-
quences of hirsutism are recognised by
some researchers to cause profound dis-
tress in affected persons7,84,87, only very
few studies are aimed at evaluating the
psychosocial factors correlated with it.
Some older investigations noted a period
of emotional stress prior to the onset of
hair growth increment88, various psycho-
logical symptoms including insecurity
with respect to the female sexual role89,
high levels of sexual dysfunction90 and
anxiety91. However, treatment with ben-
zodiazepines did not alter hirsutism92
and psychiatric illnesses were excluded
in a sample of 30 hirsute women93. A
more recent study reports that affected
women show significant higher social
fear, anxiety and psychotic symptoms
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than controls, whereas depression, soma-
tisation and anger-hostility are not sig-
nificantly different from controls7. An-
other study’s conclusion is that depres-
sion in hirsute women is significantly as-
sociated with free and biologically active
testosterone, suggesting it to be caused
rather by deranged neuroendocrine me-
chanisms than by psychosocial factors94.
Thus, it seems clear that much more
studies are needed to understand the psy-
cho-endocrine and psychosocial causes
and consequences of hirsutism.
Overweight and obesity
The prevalence of obesity is increasing
rapidly especially in western societies.
Almost 40% of North-American adult
women are obese; a proportion that as-
sumes epidemic dimensions95. Obesity is
one of the typical diseases where genetic
as well as environmental factors play key
roles. As such it is also linked to PCOS,
however, affecting only a part of the pa-
tients. Two of the obesity genes seem to
be related to reproductive functions. The
gene determining body weight homeosta-
sis-lep-96 encodes the protein leptin.
Apart from being called a »satiety« gene it
seems to be linked with ovarian function,
being able to impair estradiol synthesis,
and suggesting that leptin may indicate
whether somatic fat stores are sufficient
for growth and reproduction15,95. It is
known for long that women with very low
fat proportion, such as anorexics, athletes
and women who practice stringent
weight control, show menstrual irregu-
larities as well as reproductive failures50.
On the other extreme, high body weights
are also associated with menstrual ir-
regularity97,98. The fact that some of the
obesity genes are involved with reproduc-
tive functions is expected, since the adi-
pose tissue is the most important site of
extra-ovarian and placental estrogen
biosynthesis. There are studies reporting
the association of obesity and inferti-
lity19,99 and others where this association
was not found. Several mechanisms are
possible for the effect of weight on fertil-
ity since weigh loss reverses the pattern
of depressed sex hormone-binding globu-
lin, elevated free androgens, and exagger-
ated insulin response100.
The association of obesity and PCOS
is complex as stated above and new re-
search propose that there are three types
of disorders relating obesity, androgens,
insulin and PCOS: simple nonhyperan-
drogenic obesity, typical nonhyperinsu-
linemic PCOS and insulin-resistant
PCOS39. Whether these represent sepa-
rate genetic disorders remains to be eluci-
dated. Apart from the genetic predisposi-
tion leading to obesity, it is well establi-
shed that high BMIs (usually considered
to be BMI > 25kg/m2) lead to significant
health hazards. The most common medi-
cal complication arisen secondary to obe-
sity are increased risks for metabolic syn-
drome, osteoarthritis, gout, sleep apnoea,
dysfunction uterine bleeding and endo-
metrial carcinoma95. Especially high
waist-hip-ratios have shown a better pre-
dictive power for various forms of health
problems than classical BMI101. A high
waist to hip ratio, visible as android fat
patterning is considered as unattractive
and in contrast to female beauty ideals
independent of cultural background.
From an evolutionary point of view the
association between fertility and nutri-
tional status or fat mass can be seen as
an adaptation to periods of famine and
climatic upheaval, being referred to as
the »thrifty gene« hypothesis102. Not only
the reproductive system has evolved a
high physiologic responsiveness to envi-
ronmental change, the homeostasis of en-
ergy expenditure and energy storage
must also be prone to intense environ-
mental modification.
From corpulent, well nourished wo-
men with pink cheeks, as pictured by Pe-
ter Paul Rubens, the female beauty ideal
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changed during the last centuries of
western civilisation to extreme thin wo-
men, as personified by the model Twiggy.
Already this changes of the ideals of body
shape points towards its sensitivity to
cultural and environmental influences.
The social qualification of obesity does
not only vary from time to time, but also
from place to place, and even from sub-
group to subgroup sharing the same cul-
tural setting. For example, there is a neg-
ative association of socioeconomic status
and obesity in modern societies, which is
in contrast with the direct association of
wealth and fatness in some traditional
cultures103,104. This is to say that culture
has a very strong influence on weight105.
Apart from genetic factors, health
hazards, and cultural influences, several
psychosocial consequences also affect
obese patients. The intensity of these psy-
chosocial aspects is reflected by the mas-
sive consumption of the most different
commercially available diets and slim-
ming programs. Apart from the fact that
in some cultures, higher BMIs are associ-
ated to well-being103, negative stereoty-
pes of obesity have been found among
Australian, Black, Japanese, Puerto Ri-
can and Anglo-American ethnic groups105.
Impaired psychosocial function in the
obese is manifested as social isolation,
loss of job mobility, increased employee
absenteeism, economic and social discri-
mination and lowered self esteem101,106,107.
This, in turn, is associated with down-
ward social mobility and lower levels of
socio-economic attainment, negatively af-
fecting the patient’s quality of life, through
impairment of several physical, psycho-
logical and social factors108. There seems
to be a vicious cycle where obesity is asso-
ciated to depression, depression leading
to enhanced eating disorders that further
strengthen depressive feelings10. Besides
the fact that women are more often obese
than men, which probably is due to the
hormonal fluctuations linked to weight
gain during pregnancy and in the meno-
pause transition15,109, obese females
report to have a lower quality of life than
obese men110. This, the fact that beauty
ideals of thinness apply more to females
than males111, and a greater susceptibil-
ity to anxiety and depression among fe-
males110 may explain these gender diffe-
rences15.
Apart form obese patients, subjects af-
fected with the insulin resistance syn-
drome are also prone to psychosocial dis-
tress. A population study of men in
management positions found that psy-
chosocial stress correlated closely with
the risk factors comprising the insulin re-
sistance syndrome112. This supports the
idea that although genetic predisposition
may play an important role in the devel-
opment of this syndrome, environmental
factors are necessary or may even be of
major importance. The authors conclude
that the findings of their study stress the
importance of further investigations of
the role of stress, personality and behav-
ioural factors in metabolic alterations as
a whole112.
As seen above, symptoms like men-
strual irregularity, infertility, hirsutism
and obesity, in association and especially
each on its own may have a profound im-
pact on a woman’s quality of life. Some of
these symptoms may be caused by ge-
netic as well as environmental factors,
but all do cause psychological distress
that may threaten feminine identity, al-
ter self-perception and family dynamics.
Discussion
The studies published so far are incon-
clusive about psychosocial causes leading
to PCOS, although universal consensus
exists on more or less severe psychosocial
distress as consequence of PCOS. The
main reason for this inconclusiveness re-
lies on the fact that only very few reports
were found on this issue. However, when
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analysing the vast literature on each of
the symptoms on their own, it seems as if
psychosocial factors not only are a more
or less heavy burden consequential to the
clinical manifestations, such as infertil-
ity, but may also, at least in some in-
stances, contribute to their etiology.
What seems clear through part I of
this paper, is that genetic factors do seem
to play an important role in the etiology
of PCOS, although it is far from estab-
lished how many, and which genes are in-
volved. It seems more likely that PCOS is
a complex trait with multifactorial inher-
itance. This means that there are proba-
bly some key genes that in complex asso-
ciation with each other, with some minor
genes as well as with environmental fac-
tors contribute to this intricate and heter-
ogeneous disease.
The environmental factors most often
cited to contribute to the etiology of PCOS
are nutrition and diet. Other environ-
mental factors like a sedentary life style
may contribute in a minor way. Obesity,
especially in adolescence is predictive of
menstrual irregularities, reproductive
failures as well as PCOS. Furthermore, it
is well established that diet and nutrition
in the form of weight gain shape the
course of progression of PCOS. On the
other hand, weight loss and exercises in
obese, infertile PCOS women signifi-
cantly ameliorate menstrual cyclicity,
ovulation and pregnancy frequency in
comparison to healthy controls113. This
success may in part be due to ongoing
support gained from clinic staff and other
affected women joining a special support
group for infertility, and the relatively
short-term goal of achieving a pregnan-
cy114, thus suggesting psychosocial sup-
port to have strong influences in the ame-
lioration of some of the PCOS related
symptoms.
Since it is consensual that symptoms
like menstrual irregularity, infertility,
hirsutism and obesity trigger psychoso-
cial distress, only the evidences in favour
or against psychosocial factors contribut-
ing to the etiology of these symptoms will
be further discussed.
Menstrual irregularity can be a conse-
quence of intense psychosocial distress as
evidenced by amenorrhoea among women
kept in concentration camps, prisons and
alike. It is also consensual that intense
physical stress leads to menstrual irregu-
larities, as exemplified by athletes. On
the other hand, very low fat proportion as
observed in anorexic patients with all
their behavioural and personality prob-
lems also grossly alter menstruation.
Thus, it seems that psychosocial distress
does lead to menstrual irregularity.
Infertility is, among the four symp-
toms studied, the one that received most
attention in the past literature. Although
the number of papers on the psychosocial
aspects related to infertility is huge, the
issue whether psychosocial distress does
contribute to infertility or not is still un-
resolved. The review by Wright et al.61 in-
dicated that this hypothesis received the
least support, whereas the hypothesis on
psychosocial factors as consequences of
infertility as well as the hypothesis on the
interconnection of psychosocial factors
and infertility seemed the most probable.
Since that time research on this topic
continues, and, contrary to expectations,
there are some recent studies supporting
the idea that psychosocial distress does
contribute to the etiology of infertility.
However, this newer research points to
more subtle psychosocial as well as hor-
monal desequilibria being capable of in-
terfering with fertility. Newton et al.115
recently developed an inventory that
measures perceived infertility related
stress, rather than the intensity of stress-
ful events associated with infertility. On
the other side, different degrees and
types of psychosocial reaction are fre-
quent among infertile persons, this dis-
tress may in turn still exacerbate infertil-
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ity. Here it is important to note that very
few papers do attribute different degrees
of infertility to their patients. Guzik116
claims that the infertility tests used most
often do not really discriminate between
infertile and fertile populations. There-
fore the former question whether psycho-
social distress triggers infertility should
now be addressed in a different way: does
the intensity of the perceived stress
rather than the intensity of the stress
event itself trigger infertility? The an-
swer seems to be: yes. However, what the
underlying factors are that contribute to
the development of these differential re-
sponses towards stress still awaits fur-
ther investigation, being one of the hy-
potheses to be testes that of genetic
predisposition.
Only very few papers on psychosocial
aspects of hirsutism have been found.
Among them, some quite old studies sug-
gested an increase in hirsutism after
stressful events. However, newer re-
search seems not to address this question
anymore – so this remains utterly incon-
clusive. However, some work has been
carried out on the psychosocial conse-
quences of hirsutism, where it seems
clear that hirsutism leads to distress neg-
atively affecting the women’s quality of
life.
Finally, psychosocial factors associ-
ated with obesity have received much at-
tention in the recent years, since obesity
is rapidly increasing in affluent coun-
tries, assuming epidemic dimensions. Al-
though much research confirmed that
obesity could have serious psychosocial
consequences (depending on the degree of
obesity as well as on the cultural context),
it is not clear whether psychosocial dis-
tress can lead to the development of obe-
sity. What seems established however, is
that the psychosocial consequences of
obesity often lead to an increase of al-
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Fig. 1. Genetic, psychosocial factors and stress as vicious circle aggravating main
symptoms in PCO.
ready installed overweight, thus repre-
senting a vicious cycle. It must not be for-
gotten, nevertheless, that about half of
PCOS patients are non-obese.
From many recent endocrinological
studies, it is clear that insulin resistance
seems to play a key role in the develop-
ment of PCOS. Insulin resistance would
trigger hyperandrogenism as well as obe-
sity leading finally to PCOS. However, it
must be kept in mind that a part of the
women affected with PCOS are non-insu-
lin resistant. Although genetic predispo-
sition accounts for the insulin resistance
syndrome, psychosocial distress seems to
also be a very important factor in its etiol-
ogy, stressing the importance of further
investigations of the role of stress and
personality in other metabolic diseases.
In conclusion, we would like to present
the following model (represented in Fig-
ure 1) of the influence of genetic and
psychosocial factors on PCOS.
Due to the fact that psychosocial con-
sequences of PCOS and especially some
of its associated symptoms, like infertility
and obesity, are accepted almost univer-
sally, psychosocial support assumes an
important role in the management of the
affected patients. This should not mean,
that medical treatment of PCOS is not
necessary but an intensive collaboration
between medical treatment and psycho-
social support would improve the situa-
tion PCOS affected women.
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SINDROM POLICISTI^NIH JAJNIKA: MEDICINSKO STANJE ALI
I VA@AN PSIHOLO[KI PROBLEM
S A @ E T A K
Sindrom policisti~nih jajnika, vode}i uzrok neplodnosti uslijed izostanka ovulacije
prisutan kod petine `ena, je kompleksna kroni~na bolest s geneti~kom i okoli{nom
komponentom, no jo{ uvijek nejasne etiologije. Pored neplodnosti, sindrom policisti-
~nih jajnika izaziva menstrualne disfunkcije, hirzutizam i simptome pretilosti koji
mogu biti uzrokom ozbiljnih psiho-socijalnih tegoba. U ovom smo radu dali pregled
etiologije i simptoma sindroma policisti~nih jajnika koji nije samo vrsta bolesti koju je
potrebno medicinski tretirati ve} i psiho-socijalni problem oboljelim `enama. Sindrom
policisti~nih jajnika nije ko-induciran psiho-socijalnim ~imbenicima ve} su njegovi
glavni simptomi – neplodnost, menstrualne disfunkcije, hirzutizam i pretilost – uzroci
pove}anog psiho-socijalnog stresa.
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